• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance

tetano

Editor, Senior Moderator
J Clin Med


. 2022 Aug 23;11(17):4936.
doi: 10.3390/jcm11174936.
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance


Jousel Ora[SUP] 1 [/SUP], Bartolomeo Zerillo[SUP] 1 [/SUP], Patrizia De Marco[SUP] 2 [/SUP], Gian Marco Manzetti[SUP] 2 [/SUP], Ilaria De Guido[SUP] 2 [/SUP], Luigino Calzetta[SUP] 3 [/SUP], Paola Rogliani[SUP] 1 2 [/SUP]



Affiliations

Abstract

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to cause long-term pulmonary sequelae.
Objects: The aim of this study was to evaluate the consequences of the SARS-CoV-2 infection on pulmonary function and on the 6-min walk test related to the severity of the disease.
Methods: A cross-sectional study was conducted at the "Policlinico Tor Vergata" Academic Hospital (Rome, Italy), including 75 patients evaluated in post-COVID clinics at the Respiratory Units between November 2020 and September 2021. Complete pulmonary function tests, 6-min walk tests and persistence of symptoms were performed.
Results: Of the 75 subjects, 23 had mild, 16 moderate, 26 severe and 10 very severe COVID-19, classified according to WHO. Very severe patients had a lower FVC (100 ± 10%pr) compared to the other groups (116 ± 16%pr, 116 ± 13%pr, 122 ± 20%pr from mild to severe; p < 0.05) and a lower TLC (94 ± 13%pr) compared to the others (102 ± 10%pr, 108 ± 15%pr, 108 ± 12%pr from mild to severe; p < 0.05). DLco and DLco/VA were similar among groups. At the 6MWT, distance, rest and nadir SpO[SUB]2[/SUB] were similar among groups, but all groups presented a significant decrease in SpO[SUB]2[/SUB] from rest to nadir (Rest SpO[SUB]2[/SUB]: 97.0 ± 1.0% vs. Nadir SpO[SUB]2[/SUB]: 93.6 ± 2.7%, p < 0.01). A positive correlation was found between desaturation and delta SpO[SUB]2[/SUB] (rest-nadir) (R: 0.29, p < 0.05) and the Distance Desaturation Product (R: 0.39, p < 0.01).
Conclusions: These results showed that, although the PFTs are within the normal range, there is still a mild restrictive spirometric pattern after six months in very severe subjects. Moreover, the only persistent pathological sequalae of SARS-CoV-2 infection were a mild desaturation at 6MWT, despite the severity of the infection.

Keywords: 6MWT; COVID-19; pulmonary function test.
 
Back
Top Bottom